RE:RE:RE:Drug just got approved! :)Wow. These biopharma stocks are truly in show me stage for valuation. Great opportunity for those with high conviction (like me) to load up way more than you thought you could. Sales will start slow since it takes some time to gain momentum but imagine if sales take off faster than the market expects ... at any rate I am sitting back on a load of core shares and will buy a trading position if it goes much lower. Good chance of 10x in 12 months if Q3 / Q4 sales shows promising signs.
Might be one more bad quarter though ... hard to say how much pent up demand there is for this and how long it will take to get the marketing team to start showing results. Lots of cash to whether a slow ramp ... so that is comforting. I am done with the dilutive financings and hopefully management finally want their options to be worth something.
Wild card is Merck to buy out for $2 billiion ... if the IV drip Phase 1 shows good safety results then watch out for that. Surely management would not sell for less since they can secure a nice position with a white knight if Merck cheaps out on the offer.
Look for Merck to potentially cause a short sale though to test management resolve. All speculative but for sure they are watching carefully and hoping for a misstep on sales.
Cheers